MEDDAY'S MD1003 STUDY FAILS TO REACH PRIMARY ENDPOINT
- CureOrBust
- Family Elder
- Posts: 3367
- Joined: Wed Jul 27, 2005 2:00 pm
- Location: Sydney, Australia
Re: MEDDAY'S MD1003 STUDY FAILS TO REACH PRIMARY ENDPOINT
http://www.medday-pharma.com/news-and-e ... f-md-1003/
with this quote
MedDay wrote:Patients who received MD1003 tended to improve slightly more than patients who received the placebo (3 letters mean improvement in the MD1003 arm versus 1.8 letters in the placebo arm) however the difference did not reach statistical significance and overall the study did not meet its primary endpoint.
Re: MEDDAY'S MD1003 STUDY FAILS TO REACH PRIMARY ENDPOINT
And, like COB points out, the MD1003 worked - but not quite enough to meet statistical significance.
Also, consider what this tells us about MedDay - they are not attempting to massage the figures to make their product look better than it is. I have known researchers in the past who would wait until the data was in and then "design" the study to fit the data.
Geoff
Re: MEDDAY'S MD1003 STUDY FAILS TO REACH PRIMARY ENDPOINT
And what happened to the first study that showed positive results?
Re: MEDDAY'S MD1003 STUDY FAILS TO REACH PRIMARY ENDPOINT
If you conclude that, David, then you have failed to read the other posts in this thread.David1949 wrote:Can we conclude then that MD1003 is another dud?
And what happened to the first study that showed positive results?
The latest MD1003 trial was directed specifically at Trigeminal Neuralgia.
Far from being a dud, it worked. It did not work well enough to reach the relevant value for statistical significance for the number of participants involved in the trial. As a general guide, the lower the number of participants, the larger the required value of p
As for the first study, the results have been presented at several conferences, and have generated a considerable amount of interest.
They have also led to the creation of several Facebook groups, at least one blog, have led to threads on several of the MS forums world wide, and you can find quite a lot about it here on TiMS.
The results of that study did meet statistical significance.
Geoff
-
- Similar Topics
- Replies
- Views
- Last post
-
- 4 Replies
- 1158 Views
-
Last post by jimmylegs
Fri Apr 26, 2019 12:03 pm
-
-
Diroximel fumarate phase III study
by NHE » Wed Jul 01, 2020 6:18 am » in Vumerity (diroximel fumarate) - 0 Replies
- 551 Views
-
Last post by NHE
Wed Jul 01, 2020 6:18 am
-
-
-
Ofatumumab Phase IIb Trial, MIRROR Study
by NHE » Sat Aug 22, 2020 4:05 am » in Kesimpta (Ofatumumab) - 0 Replies
- 221 Views
-
Last post by NHE
Sat Aug 22, 2020 4:05 am
-
-
-
2018 study: sat fat, veggies and relapse rate
by jimmylegs » Sun May 12, 2019 12:26 pm » in Parenting Kids With MS - 0 Replies
- 2658 Views
-
Last post by jimmylegs
Sun May 12, 2019 12:26 pm
-
-
- 0 Replies
- 6330 Views
-
Last post by jimmylegs
Sun May 12, 2019 12:49 pm
-
-
1976 study: Vitamin D resistance in magnesium deficiency
by jimmylegs » Sun May 19, 2019 11:57 am » in Natural Approach - 0 Replies
- 928 Views
-
Last post by jimmylegs
Sun May 19, 2019 11:57 am
-
-
-
New study: Cerebral hemodynamics in patients with multiple sclerosis
by ThisIsMA » Sun Aug 02, 2020 7:22 pm » in Chronic Cerebrospinal Venous Insufficiency (CCSVI) - 0 Replies
- 297 Views
-
Last post by ThisIsMA
Sun Aug 02, 2020 7:22 pm
-
-
-
2016 study: cu/zn ratio as a diagnostic marker for taste disorders
by jimmylegs » Sun Feb 23, 2020 1:46 pm » in Natural Approach - 0 Replies
- 6282 Views
-
Last post by jimmylegs
Sun Feb 23, 2020 1:46 pm
-
-
-
2005 study: lifestyle influences on antioxidant essential nutrient status
by jimmylegs » Fri May 17, 2019 3:18 am » in Natural Approach - 0 Replies
- 919 Views
-
Last post by jimmylegs
Fri May 17, 2019 3:18 am
-